TG
IRWD icon

TCW Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

TCW Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-70,319
Closed -$770K – 671
2016
Q2 		$770K Sell
70,319
-227
-0.3% -$2.22K 0.01% 544
2016
Q1 		$646K Sell
70,546
-4,878
-6% -$40.2K ﹤0.01% 591
2015
Q4 		$732K Buy
75,424
+2,442
+3% +$23.6K 0.01% 579
2015
Q3 		$637K Sell
72,982
-23,999
-25% -$224K ﹤0.01% 613
2015
Q2 		$980K Buy
96,981
+21,193
+28% +$246K 0.01% 533
2015
Q1 		$1.01M Buy
75,788
+21,910
+41% +$287K ﹤0.01% 704
2014
Q4 		$691K Buy
53,878
+4,836
+10% +$55.3K ﹤0.01% 700
2014
Q3 		$532K Sell
49,042
-239
-0.5% -$2.74K ﹤0.01% 712
2014
Q2 		$633K Sell
49,281
-234,792
-83% -$2.55M ﹤0.01% 710
2014
Q1 		$2.93M Sell
284,073
-713,872
-72% -$8.03M 0.01% 609
2013
Q4 		$9.7M Sell
997,945
-384,549
-28% -$3.45M 0.04% 334
2013
Q3 		$13.7M Sell
1,382,494
-461,817
-25% -$4.53M 0.06% 256
2013
Q2 		$15.4M Buy
+1,844,311
New +$22.4M 0.08% 220

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCW Group's IRWD Position: Q3 2016 in Review

TCW Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2016, closing a stake of 70,319 shares — an estimated $770K sold.

TCW Group first reported a position in IRWD in Q2 2013 and held it in 13 quarters. The position peaked at $15.4M in Q2 2013. 155 funds tracked by Wall St. Rank hold IRWD as of Q3 2016.

  • TCW Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • TCW Group sold 70,319 Ironwood Pharmaceuticals shares in Q3 2016, an estimated $770K.
  • TCW Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • TCW Group's Ironwood Pharmaceuticals position peaked at $15.4M in Q2 2013.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2016.

Based on TCW Group's 13F filing for Q3 2016, filed 14 Nov 2016.